Dr. Davey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Rockville Pike
Bethesda, MD 20892Phone+1 301-496-8029Fax+1 301-480-5560
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1984 - 1987
Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
Certifications & Licensure
MD State Medical License 1984 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies Start of enrollment: 1984 Jan 09
- Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies Start of enrollment: 2003 Dec 01
- Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study Start of enrollment: 2008 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- 661 citationsHIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionRichard T. Davey, Niranjan Bhat, Christian Yoder, Tae Wook Chun, Julia A. Metcalf
Proceedings of the National Academy of Sciences of the United States of America. 1999-12-21 - 924 citationsA Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.Sabue Mulangu, Lori E. Dodd, Richard T. Davey, Tshiani Mbaya O, Proschan M
The New England Journal of Medicine. 2019-12-12 - 270 citationsSensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.Peter D. Burbelo, Francis X. Riedo, Chihiro Morishima, Stephen A. Rawlings, Davey M. Smith
The Journal of Infectious Diseases. 2020-06-29
Journal Articles
- Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 TranslationRichard T Davey, John H Beigel, British Journal of Clinical Pharmacology
Grant Support
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2009–2011
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2009–2011
- Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2007–2008
- Immunologic And Virologic Approaches To HIV-1 TherapeutiNational Institute Of Allergy And Infectious Diseases2002–2006
- Immunologic/Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2005
- Immunologic &Virologic Approaches To HIV 1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2001
- Immunologic And Virologic Approaches To HIV1 TherapeuticNational Institute Of Allergy And Infectious Diseases2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
